Industry
Pfizer Acquires COVID-Flu Test Developer Lucira Health for USD 36.4 Million
Pfizer acquired Lucira Health for USD 36.4 million in a bankruptcy auction. Lucira stated that a lengthy EUA process for its COVID-19 and influenza test had proved expensive, leading to the bankruptcy filing and sale process. More...02 May 2023
Global POC Molecular Diagnostic Market Driven By Growing Demand for Near-Patient Testing
The increasing prevalence of infectious diseases and cancer, as well as the advantages and benefits of POC molecular diagnostics, are driving demand. Consequently, the global POC molecular diagnostics market is expected to grow at a CAGR of 8.5% between 2023 and 2031. More...25 Apr 2023
Tianlong Exhibits Brand-New All-in-One Molecular Diagnosis System at analytica Vietnam 2023
Tianlong Science and Technology, an innovative high-tech company specializing in molecular diagnostic products, is attending analytica Vietnam 2023, marking the first time Tianlong is exhibiting in Vietnam. More...19 Apr 2023
Global Urinalysis Test Market Driven by Increasing Prevalence of Chronic Kidney Disease and Diabetes
The global urinalysis test market, valued at USD 3.19 billion in 2021, is projected to experience a CAGR of 6.7% from 2022 to 2031, reaching USD 6.12 billion by 2031, driven by the rising prevalence of chronic diseases. More...14 Apr 2023
Global Antimicrobial Resistance Diagnostics Market Driven by Increasing Hospital-Acquired Infections
The global market for antimicrobial resistance diagnostics is expected to reach USD 5.7 billion by 2028, registering a CAGR of 6.1% during the forecast period 2022-2028. The market growth will be driven by the availability of better diagnostic tests and kits, as well as the increasing incidence of hospital-acquired infections. More...31 Mar 2023
Cardiac Troponin Diagnostics Market Driven by Demand for High Sensitivity POC Testing
The global market for cardiac troponin (cTn) diagnostics is expected to achieve a compound annual growth rate (CAGR) of 2.4%, reaching USD 2.28 billion by 2025 from USD 2.07 billion in 2021, driven by a rise in the number of patients with cardiac complaints visiting emergency departments and the increasing adoption of high-sensitivity POCT cTn assays by hospitals and clinical laboratories, which can detect troponin in lower concentrations and shorten the timeline for MI detection. More...27 Mar 2023
Roche and Eli Lilly Collaborate on Innovative Blood Test for Early Diagnosis of Alzheimer's
Roche has entered into a collaboration with Eli Lilly to support the development of Roche’s Elecsys Amyloid Plasma Panel (EAPP) - an innovative blood test that aims to facilitate the earlier diagnosis of Alzheimer’s disease. More...23 Mar 2023
Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
.jpg)
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Urine Analyzer
respons® UDS100
Pipette Calibration System
Artel PCS®
In Other News
Integra Biosciences Acquires Biotechnology Specialist Miroculus to Advance Genomics Discoveries
Enzo Biochem Sells Clinical Laboratory Division to Labcorp
Werfen Completes Immucor Acquisition to Expand Leadership in Specialized Diagnostics
PerkinElmer Transforms into New Life Sciences & Diagnostics Company with Completion of Business Divestitures
Siemens and Sysmex Sign Global Hemostasis Supply Agreement
Siemens Partners with Hamamatsu to Expand Into Digital Pathology in Americas and Europe
Global Urinalysis Market Driven by Growing Demand for Point-of-Care Diagnostic Testing
Global Microbiology Diagnostic Devices and Equipment Market Driven by Emergence of Novel Pathogens
DiaSorin’s Luminex Subsidiary to Spin Off Flow Cytometry Business to Cell Analysis Leader
Next-Generation Sequencing (NGS) Market Driven by Launch of Technologically Advanced Systems
Global Hemostasis Analyzers Market Driven by Increasing Awareness of Blood Disorder Conditions
Chembio and Biosynex to Merge, Forging US-French Point-of-Care Testing Powerhouse
CerTest to Run ‘More than Diagnostics’ Campaign Throughout 2023
New Collaboration to Apply Power of AI to Digital Pathology Images
Point-of-Care Glucose Testing Market to Reach Almost USD 6 Billion by 2032
Carolina Liquid Chemistries and Diazyme Enter Into Partnership
Siemens Launches Centre of Excellence for Immunoassay Instrument R&D in Ireland
Medlab Middle East Sees 100% Increase in Exhibitor Numbers
Thermo Fisher Completes Acquisition of UK’s Binding Site
Tianlong’s PCR Lab Solution Safeguards 2022 G20 Indonesia Summit
Tianlong Contributes to China’s Power to Prevent and Control Global Epidemics
Global Urinalysis Market Driven by Increasing Burden of UTIs, Diabetes, and Kidney & Liver Diseases
Fujifilm Enters Digital Pathology Space with Acquisition of Inspirata
LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.